Minerva Neurosciences, Inc. (NERV) Revenue History
Annual and quarterly revenue from 2012 to present
NERV Revenue Over Time (2012–2025)
NERV Revenue Growth History
0 of 1 years with positive growth- FY2012 revenue growth
- N/A
- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- -100.0%
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
| Q1 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
NERV Revenue Analysis (2012–2025)
Current Revenue & Growth
As of June 13, 2026, Minerva Neurosciences, Inc. (NERV) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
NERV's historical revenue data shows various trends over time. Minerva Neurosciences, Inc.'s highest annual revenue of $41.2 million was recorded in 2020.
Peer Comparison
Compared to Healthcare sector peers — including ACAD (+9.9% YoY), INVA (+13.6% YoY), and AXSM (+63.9% YoY). Compare NERV vs ACAD →
NERV Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 NERVCurrent | $0 | - | - | - | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 AXSM | $638M | +63.9% | - | -26.5% | |
 ALTO | $918M | -3.7% | +0.5% | 0.8% | |
 NRXP | $1M | - | - | -1324.4% |
NERV Historical Revenue Data (2012–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-15,102,970 | - |
| 2024 | $0 | - | $0 | - | $-21,848,386 | - |
| 2023 | $0 | - | $0 | - | $-23,119,576 | - |
| 2022 | $0 | - | $0 | - | $-25,231,326 | - |
| 2021 | $0 | -100.0% | $0 | - | $-45,365,657 | - |
| 2020 | $41.2M | - | $41.2M | 100.0% | $1.8M | 4.5% |
| 2019 | $0 | - | $-162,000 | - | $-75,865,000 | - |
| 2018 | $0 | - | $-17,467 | - | $-51,730,000 | - |
| 2017 | $0 | - | $-11,094 | - | $-41,170,000 | - |
| 2016 | $0 | - | $-16,530 | - | $-30,191,000 | - |
| 2015 | $0 | - | $-17,276 | - | $-26,110,000 | - |
| 2014 | $0 | - | $0 | - | $-54,870,000 | - |
| 2013 | $0 | - | $0 | - | $-3,175,000 | - |
| 2012 | $0 | - | $0 | - | $-1,581,000 | - |
What if you invested $1,000 in NERV back in 2012?
Total return with dividends reinvested · 14+ years of data
Calculate ReturnsHow much would $100/month in NERV be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs NERV Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationNERV vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowNERV — Frequently Asked Questions
Quick answers to the most common questions about buying NERV stock.
Is NERV's revenue growth accelerating or slowing?
NERV TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NERV's revenue history from 2012 to 2026?
Minerva Neurosciences, Inc. (NERV) revenue history spans 2012 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is NERV's long-term revenue growth rate (CAGR)?
Minerva Neurosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for NERV.
Why does NERV's quarterly revenue fluctuate?
NERV quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Minerva Neurosciences, Inc.'s revenue data from 2012 to 2026 shows full historical quarterly detail on this page.
How is NERV's revenue distributed by segment?
NERV reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does NERV's revenue compare to industry peers?
Minerva Neurosciences, Inc. (NERV) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.